rss Posted August 13, 2015 Report Share Posted August 13, 2015 Erythema of Rosacea: Validation of Patient's Self-Assessment Grading Scale. J Drugs Dermatol. 2015 Aug 1;14(8):841-844 Authors: Tan J, Leoni M Abstract BACKGROUND: Facial erythema is a primary feature of rosacea. Currently, no validated scales exist that can accurately capture a patient's self-assessment of their own facial erythema. During phase 2 studies for brimonidine tartrate gel, a 5-point numeric rating scale was developed as a tool to allow subjects to provide an independent assessment of visible changes to the facial erythema associated with their rosacea.<br /> OBJECTIVE: The objective of this study was to validate the revised patient's self-assessment (PSA) scale and evaluate it for statistical reliability and validity in quantification of facial erythema of rosacea.<br /> METHODS: The validity of the PSA scale was evaluated by assessing the test-retest reliability, construct validity, and known-groups validity based on the data collected during a Phase 2b study on brimonidine gel for the treatment of persistent facial erythema of rosacea.<br /> RESULTS: Based on the results of this evaluation, this PSA scale demonstrated test-retest reliability, construct validity, and known-groups validity.<br /> LIMITATIONS: Study results are most generalizable to those with moderate to severe erythema.<br /> CONCLUSION: The PSA is an appropriate scale to assess facial erythema associated with rosacea.<br /><br /> <em>J Drugs Dermatol.</em> 2015;14(8):841-844.PMID: 26267728 [PubMed - as supplied by publisher] http://www.ncbi.nlm.nih.gov/pubmed/26267728?dopt=Abstract = URL to article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now